Co-prescribing of medications with anticholinergic properties to those using cholinesterase inhibitors for dementia
Author: Garrigan, Katherine; John, N; McGrogan, A; Jones, R; de-Vries, C
Publisher: John Wiley & Sons, Ltd.
Type: Conference item
Link to this item using this URL: http://hdl.handle.net/2292/18890
Medications with anticholinergic (AC) prop- erties have adverse effects on cognition and many guidelines recommend avoiding them in older adults. Theoretically they could negate beneﬁts of cholinesterase inhibitor (CI) treatment in patients dementia patients, although there is inadequate evidence to date.
Citation: ["The 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 Aug 2010 - 22 Aug 2010. Pharmacoepidemiology and Drug Safety. John Wiley & Sons, Ltd.. 19: S48-S48. Aug 2010"]